Clinical Trial Update: Phase I Trial of Everolimus, Pomalidomide and Dexamethasone in Patients With Relapsed/Refractory Multiple Myeloma [Phase 1]

View source ↗

Summary

Phase I trial evaluating everolimus, pomalidomide, and dexamethasone in relapsed/refractory multiple myeloma; the study was terminated and results were posted i…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Myeloma

Drugs mentioned

• Afinitor (everolimus)
• DEXAMETHASONE (Dexamethasone)
• Pomalyst (pomalidomide)

Snippet

Sponsor: New Mexico Cancer Research Alliance | Conditions: Multiple Myeloma in Relapse | Phase 1 | Status: TERMINATED | Results posted: 2015-07-31